SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 344 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,031,800 | +136.6% | 190,000 | +123.5% | 7.58% | +135.8% |
| Q2 2023 | $9,734,200 | -61.8% | 85,000 | -54.1% | 3.21% | -57.4% |
| Q1 2023 | $25,499,000 | +257.8% | 185,000 | +236.4% | 7.54% | +147.7% |
| Q4 2022 | $7,127,000 | -41.4% | 55,000 | -50.0% | 3.04% | -10.8% |
| Q3 2022 | $12,159,000 | +24.8% | 110,000 | -15.4% | 3.41% | -32.8% |
| Q2 2022 | $9,745,000 | +149.5% | 130,000 | +160.0% | 5.08% | +498.6% |
| Q1 2022 | $3,906,000 | -56.6% | 50,000 | -50.0% | 0.85% | -73.7% |
| Q4 2021 | $9,005,000 | +32.0% | 100,000 | +150.0% | 3.23% | +112.3% |
| Q4 2020 | $6,820,000 | -25.3% | 40,000 | -38.5% | 1.52% | -42.4% |
| Q3 2020 | $9,128,000 | +8.8% | 65,000 | 0.0% | 2.64% | +65.2% |
| Q4 2019 | $8,388,000 | -73.5% | 65,000 | -84.5% | 1.60% | -80.2% |
| Q3 2019 | $31,634,000 | -28.2% | 420,000 | +44.8% | 8.06% | -11.8% |
| Q2 2019 | $44,066,000 | +476.9% | 290,000 | +314.3% | 9.14% | +229.7% |
| Q4 2018 | $7,639,000 | -77.5% | 70,000 | -66.7% | 2.77% | -61.5% |
| Q3 2018 | $33,917,000 | +46.6% | 210,000 | +20.0% | 7.21% | +5.9% |
| Q2 2018 | $23,132,000 | +32.9% | 175,000 | -25.5% | 6.81% | +93.3% |
| Q1 2018 | $17,411,000 | +283.8% | 235,000 | +135.0% | 3.52% | +265.7% |
| Q3 2017 | $4,536,000 | -17.3% | 100,000 | -50.0% | 0.96% | -27.0% |
| Q4 2016 | $5,486,000 | -90.1% | 200,000 | -77.8% | 1.32% | -85.3% |
| Q3 2016 | $55,270,000 | +383.0% | 900,000 | +50.0% | 8.96% | +171.3% |
| Q2 2016 | $11,442,000 | +196.6% | 600,000 | +500.0% | 3.30% | +109.1% |
| Q4 2015 | $3,858,000 | +1101.9% | 100,000 | +900.0% | 1.58% | +997.2% |
| Q3 2015 | $321,000 | – | 10,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |